Luke M. Beshar, SVP &CFO at NPS PHARMACEUTICALS INC (NPSP), sold 50,000 shares at $10.00 ($500K) on 2011-01-31, disclosed to the SEC on 2011-02-02.
Scheduled sale ($500k) by SVP &CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| TARA | BUY | 2022-03-14 | $45K | — | Filing → |
| RGNX | SELL | 2018-12-03 | $831K | — | Filing → |
| RGNX | SELL | 2018-11-28 | $2.6M | — | Filing → |